Federal Trade Commission building in Washington, D.C. Photo: Diego M. Radzinschi/ALM
.Two Republican nominees for seats on the Federal Trade Commission were grilled at their Senate confirmation hearing Wednesday on how aggressively the FTC should regulate pharmacy benefit managers—the so called "middle men" in the pharmaceutical supply chain.
"Having access to affordable prescription drugs is an important issue for Americans," Melissa Holyoak told the Senate Committee on Commerce, Science, and Transportation. Holyoak, now Utah's solicitor general, said she supports the agency taking a more aggressive stance in regulating the industry.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Maydeen Merino
Maydeen Merino is a regulatory reporter, covering the DOJ, FTC, SEC and EPA. She can be reached at [email protected].
